PD-1-IN-17 TFA |
| カタログ番号GC34929 |
PD-1-IN-17 TFA は、特許 WO2015033301A1、化合物 12 から抽出されたプログラム細胞死 1 (PD-1) 阻害剤であり、100 nM で 92% の脾細胞増殖を阻害します。
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
PD-1-IN-17 TFA is a programmed cell death- 1 (PD-1) inhibitor extracted from patent WO2015033301A1, Compound 12, inhibits 92% splenocyte proliferation at 100 nM[1]. PD-1[1]
[1]. Pottayil Govindan Nair Sasikumar, et al. 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators. WO2015033301A1.
Review for PD-1-IN-17 TFA
Average Rating: 5 (Based on Reviews and 26 reference(s) in Google Scholar.)
Review for PD-1-IN-17 TFA
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *